Lanthanide chalcogenolates react with either TeO(2) in pyridine or py-SO(3) in THF to give oxychalcogenido clusters. The sulfido derivatives (THF)(8)Ln(8)S(2)O(2)(SePh)(16) (Ln = Ce, Nd) are isostructural with previously reported oxoselenido compounds, and must be prepared at low temperatures to avoid the introduction of Se into the sulfide position. Analogous telluride derivatives for the early lanthanides were not obtained, but reactions of in situ prepared Ln(TePh)(3) with elemental Te and TeO(2) gave a complicated heterocluster product, with tetrametallic polytelluride [(py)(7)Ln(4)(mu(4)-Te)(mu(2)-Te(2))(2)(mu-eta(2)-eta(2)-Te(2)Te(Ph)Te(2))(TePh)] co-crystallizing with the oxotellurido compound [(py)(5)Ln(3)(mu(3)-O)(mu(2)-Te(2))(3)(TePh)] (Ln = Ho, Er).
View Article and Find Full Text PDFLn(OC(6)F(5))(3) form stable, isolable compounds with 1,2-dimethoxyethane (DME). Monomeric (DME)(2)Ln(OC(6)F(5))(3) (Ln = Nd, Er, Tm) adopt seven coordinate structures with two chelating DME and three terminal phenoxide ligands. Both (py)(4)Er(OC(6)F(5))(3) and (THF)(3)Yb(OC(6)F(5))(3) were also prepared and structurally characterized, with the latter being a mer-octahedral compound with bond lengths that are geometry dependent.
View Article and Find Full Text PDFThe fluorinated phenoxide OC6F5 forms the stable Eu(II) and Eu(III) derivatives (DME)2Eu(mu-OC6F5)3Eu(mu-OC6F5)3Eu(DME)2 and (DME)2Eu(OC6F5)3, as well as the heterovalent product (DME)2Eu(mu-OC6F5)3Eu(DME)(OC6F5)2, in redox reactions of Eu with HOC6F5 or in proton-transfer reactions of HOC6F5 with Eu(SPh)2. The divalent complex crystallizes as a trimer with three bridging phenoxides bridging each pair of metals, with the terminal metals coordinating DME and the central metal ion encapsulated totally by O(C6F5) and dative fluoride interactions. The trivalent compound is monomeric with terminal phenoxide ligands and no Eu-F interactions.
View Article and Find Full Text PDFThe title polyanion is the first hybrid borophosphate-phenylphosphonate polyoxometalate. It was structurally characterized as its imidazolium salt, (C(3)N(2)H(5))(5)[Mo(12)O(30)(BPO(4))(2)(O(3)P-Ph)(6)].H(2)O (monoclinic, P2(1)/c, a = 22.
View Article and Find Full Text PDF